#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2432	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2299	195.6	0	.	n	.	0	C451T	SNP	451	451	C	676	676	T	230	T,C	69,77	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2432	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2299	195.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1409	1409	C	275	C	166	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2432	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2299	195.6	0	HET	.	.	.	C1450T	.	1450	1450	C	1675	1675	C	234	C,T	119,28	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	2432	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2299	195.6	0	HET	.	.	.	C207T	.	207	207	C	432	432	C	198	C,T	77,51	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3679	216.2	0	.	n	.	0	T695C	SNP	695	695	T	1016	1016	C	296	C	180	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3679	216.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2292	2292	C	180	C	105	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3679	216.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2366	2366	A	186	A	112	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	4346	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3679	216.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2918	2918	C	238	C	156	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	114	folP	855	855	100.0	folP.l15.c4.ctg.1	1435	15.2	1	SNP	p	R229S	1	.	.	685	687	AGC	905	907	AGC	15;15;15	A;G;C	10;10;10	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	356	gyrA	2751	2289	99.83	gyrA.l15.c4.ctg.1	2512	20.4	1	SNP	p	S91F	1	.	.	271	273	TTC	494	496	TTC	27;27;27	T;T;C	13;15;15	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	356	gyrA	2751	2289	99.83	gyrA.l15.c4.ctg.1	2512	20.4	1	SNP	p	D95G	1	.	.	283	285	GGC	506	508	GGC	30;30;30	G;G;C	16;16;15	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	356	gyrA	2751	2289	99.83	gyrA.l15.c4.ctg.1	2512	20.4	1	SNP	p	G95N	0	.	.	283	285	GGC	506	508	GGC	30;30;30	G;G;C	16;16;15	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	1	356	gyrA	2751	369	100.0	gyrA.l15.c4.ctg.2	587	20.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	104	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1205	16.6	1	SNP	p	G45D	0	.	.	133	135	GGC	465	467	GGC	31;31;31	G;G;C	18;18;18	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	88	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	727	19.1	0	.	n	.	0	A197.	DEL	197	197	A	320	320	A	26	A	19	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	21.1	1	SNP	p	D86N	0	.	.	256	258	GAC	411	413	GAC	16;17;18	G;A;C	7;7;10	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	21.1	1	SNP	p	R87I	0	.	.	259	261	CGT	414	416	CGT	19;20;21	C;G;T	9;8;8	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	21.1	1	SNP	p	S87R	1	.	.	259	261	CGT	414	416	CGT	19;20;21	C;G;T	9;8;8	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	21.1	1	SNP	p	R87W	0	.	.	259	261	CGT	414	416	CGT	19;20;21	C;G;T	9;8;8	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	302	parC	2304	2304	100.0	parC.l15.c4.ctg.1	2633	21.1	1	SNP	p	S88P	0	.	.	262	264	TCC	417	419	TCC	21;21;21	T;C;C	11;11;11	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	318	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2938	20.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1675	1677	GGC	18;18;18	G;G;C	12;11;12	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	0	.	p	.	0	L535I	NONSYN	1603	1605	CTT	2123	2125	ATT	8;8;8	A;T;T	5;6;6	.	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	0	.	p	.	0	Y536D	NONSYN	1606	1608	TAC	2126	2128	GAC	8;8;7	G;A;C	5;5;5	.	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	0	.	p	.	0	S553F	NONSYN	1657	1659	TCC	2177	2179	TTC	11;11;11	T;T;C	4;5;6	.	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	0	.	p	.	0	I556fs	FSHIFT	1666	1666	A	2187	2187	T	11	T	5	.	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	A311V	0	.	.	931	933	GCC	1451	1453	GCC	49;49;49	G;C;C	28;30;31	penA.52.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	I312M	1	.	.	934	936	ATG	1454	1456	ATG	50;50;50	A;T;G	31;31;29	penA.52.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	V316T	1	.	.	946	948	ACC	1466	1468	ACC	52;52;52	A;C;C,A	33;33;33,1	penA.52.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	T316P	0	.	.	946	948	ACC	1466	1468	ACC	52;52;52	A;C;C,A	33;33;33,1	penA.52.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1967	1969	ACC	31;31;31	A;C;C	19;18;19	penA.52.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2021	2023	GCG	23;24;24	G;C;G	14;12;14	penA.52.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2021	2023	GCG	23;24;24	G;C;G	14;12;14	penA.52.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2144	2146	GGT	11;11;11	G;G;T	6;6;8	penA.52.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.52.001	penA.52.001	1	1	531	396	penA	1683	1683	99.64	penA.l15.c4.ctg.1	2214	32.4	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2153	2155	AGC	10;10;10	A;G;C	5;5;5	penA.52.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	714	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3128	39.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1612	1614	CCG	22;22;22	C;C;G	13;16;13	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	214	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1633	25.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	585	585	C	11	C	9	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	262	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1668	28.1	1	SNP	p	G120K	1	.	.	358	360	AAG	660	662	AAG	24;24;24	A;A;G	14;14;13	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	262	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1668	28.1	1	SNP	p	N121D	0	.	.	361	363	AAC	663	665	AAC	24;24;24	A;A;C	13;15;13	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	262	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	1668	28.1	1	SNP	p	A121N	1	.	.	361	363	AAC	663	665	AAC	24;24;24	A;A;C	13;15;13	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1024	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4919	39.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	80	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	972	15.9	1	SNP	p	V57M	1	.	.	169	171	ATG	479	481	ATG	32;30;30	A;T;G	20;18;19	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
